Navigation Links
Vyta Corp Acquires 100% Ownership of BIOAGRA, LLC
Date:11/5/2008

DENVER, Nov. 5 /PRNewswire-FirstCall/ -- Vyta Corp (OTC Bulletin Board: VYTC) today announced that it has reached a favorable settlement in its foreclosure litigation against BIOAGRA, LLC. Pursuant to the terms of the amicable agreement, Vyta Corp now controls 100% ownership interest in BIOAGRA, LLC, and Paul H. Metzinger, President and CEO of Vyta Corp, becomes the sole Manager, and only executive officer of BIOAGRA, LLC. Terms of the agreement are included in a Form 8-K filed today with the Securities and Exchange Commission, and can be viewed on its website at (http://www.sec.gov).

BIOAGRA, LLC manufactures, markets and distributes AGRASTIM(R), a proprietary all-natural, biologically active yeast Beta-1,3/1,6-D-glucan feed supplement. AGRASTIM(R) has been listed by The Organic Materials Review Institute (OMRI) as approved for use in organic production.

About Vyta Corp

Vyta Corp, based in Denver, Colorado, is traded on the over-the-counter NASDAQ stock market (OTCBB: VYTC) as well as on the Frankfurt, Hamburg, XETRA and Munich Exchanges (OTC: VYTA).

In addition to its 100% ownership of BIOAGRA, LLC, Vyta Corp owns various patents and intellectual properties related to NCS(R) (NanoPierce Connection System) an advanced electronic connection system. For more information on Vyta Corp, please visit its website at http://www.vytacorp.com .

About BIOAGRA, LLC

BIOAGRA, LLC is based in Hinesville, Georgia, where it produces, markets and sells AGRASTIM(R), a purified, all natural, nontoxic yeast Beta 1,3/1,6-D glucan product with a high bioactivity function that improves the immune systems of animals and humans. AGRASTIM(R) is also used to replace growth promotion antibiotics that are currently used in the feed of the beef and dairy cattle, equine, swine, poultry and aquaculture industries.

This announcement contains forward-looking statements about Vyta Corp that may involve risks and uncertainties. Important factors relating to the Company's operations could cause results to differ materially from those in forward-looking statements and further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC website ( http://www.sec.gov ). All forward-looking statements are based on information available to Vyta Corp on the date hereof and Vyta Corp assumes no obligation to update such statements.

Contacts:

Vyta Corp

Paul H. Metzinger

President & Chief Executive Officer

370 17th St.

Suite 3640

Denver, CO 80202

303-592-1010

Fax: 303-592-1054

E-mail: paul@vytacorp.com


'/>"/>
SOURCE Vyta Corp
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Affitech Acquires Pharmexas Diabody Technology
2. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
3. CPA Acquires Renowned German Patent Research Specialist, SVPG
4. Circassia Acquires North American and Japanese Rights to Dopexamine
5. Advanced Instruments Acquires D & F Control Systems Inc.
6. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
7. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
8. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
9. Safecor Health Acquires Unit-Dose Pharmaceutical Leader RSC
10. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
11. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... generally produce small, heterogeneous samples with limited tumor content in a large background ... be resolved, such as the need for reliable detection of low abundance somatic ...
(Date:3/27/2017)... Md. , March 27, 2017  The ... billion for 2016, according to a new report ... medical lab testing is performed to evaluate disease ... individual therapy, among other reasons.  The healthcare market ... Market , provides an overview of the ...
(Date:3/27/2017)... DUBLIN , March 27, 2017 ... access to a comprehensive library of reports on Valero ... the transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... is biofuel production to go green. Ethanol today, even though ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research ... customizable vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video ... ways of treating coronary artery disease (CAD). Lam is an assistant professor at ...
Breaking Biology Technology:
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market ... the next decade to reach approximately $14.21 billion by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):